A Phase 3 interventional study of rectal misoprostol 600mg in Post Partum Hemorrhage, sponsored by sarah mohamed hassan. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2018-03-13.
Sponsored by sarah mohamed hassan · Phase 3, Interventional, and Prevention
comparison of the effect of misoprostol before and after cesarean on the blood loss
70 women who received 600 mg misoprostol rectally preoperatively versus 70 women who received 600 mg misoprostol postoperatively at operating theatre
Exclusion Criteria:
70 women who received 600 mg misoprostol rectally preoperatively before cesarean section
Drug: rectal misoprostol 600mg
70 women who received 600 mg misoprostol postoperatively at operating theatre after cesarean section
Drug: rectal misoprostol 600mg
70 women who received 600 mg misoprostol postoperatively at operating theatre
intraoperative blood loss
Difference in weight of linen towels (gm)+Volume of contents of suction bottle (ml)
Time frame: the operation time
postoperative blood loss
weighing the soaked napkins after collection of soaked towel
Time frame: every 6 hours during first 24 hours.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
sarah mohamed hassan